There are mainly two types of Inﬂammatory bowel diseases (IBD): Ulcerative colitis (UC) and Crohn’s disease (CD).
Both UC and CD are chronic, relapsing, remitting, inﬂammatory conditions of the gastrointestinal (GI) tract that are often progressive in nature. UC only involves the large intestine as opposed to CD which can aﬀect any part of the GI tract from mouth to anus. The cause of UC or CD is not fully understood, however recent research suggests hereditary, genetics, environmental factors and/or an abnormal immune response to microbial antigens in genetically predisposed individuals can lead to UC or CD.
In Belgium, more than 30.000 patients suﬀer from inﬂammatory bowel diseases.
Takeda Belgium aims at improving the lives of patients with GI diseases through the delivery of innovative medicines and with dedicated patient disease management support, both for patients and healthcare professionals.
C-ANPROM/BE/ENTY/0060 - Feb 2022